Effect of Luteal- Phase Gonadotropin- Releasing Hormone Agonist Administration on Clinical Pregnancy Rate after Intracytoplasmic Sperm Injection

ZHOU Han-ying,SHI Juan-zi,XUE Xia,MENG Bin,YU Lin,TIAN Li,BO Hai-yan,WANG Hui
DOI: https://doi.org/10.3969/j.issn.1672-2353.2011.15.018
2011-01-01
Abstract:Objective To evaluate the effect of gonadotropin-releasing hormone(GnRH) agonist,administered in the luteal-phase,on intracy to plasmic sperm injection(ICSI) outcome.Methods 300 intracytoplasmic sperm microinjection-embryo transfer cases were divided into experimental and control groups,transplantation at single days as the experimental group.3 days after transplantation,GnRHa group was given a single subcutaneous injection of 0.1 mg of GnRHa,control group did not.Serum hormone levels,implantation rate and clinical pregnancy rate of change in patients before and after treatment were compared.Results There was 51.25% clinical pregnancy rate in the GnRH agonist group,and 45% in the control group.The rate of implantation, clinical pregnancy,abortion and live birth were similar in the GnRH agonist and control group likewise.Conclusion Luteal-phase GnRH agonist administration does not seem to enhances ICSI clinical outcomes.
What problem does this paper attempt to address?